Academic, non-commercial, and commercial researchers will be eligible to apply to use samples and/or data from the UK ME/CFS Biobank if they present a sound scientific rationale for the proposed study and have a good research track record. Eligible researchers must be supported by their institution.
All research proposals intending to use samples from the UK ME/CFS Biobank must be developed in line with the Biobank’s mission. Proposals intending to develop the following types of studies will be prioritised:
o testing or generating new hypotheses on the mechanisms (pathophysiology) of ME/CFS,
o improving diagnosis (biomarkers) and phenotyping, and/or,
o basic science, e.g. pharmacological in vitro studies potentially leading to clinical trials on therapeutic approaches.
To start the process please have a look at the UK MECFS Biobank Outline Application, which must be approved by the UK ME/CFS Biobank Guardian Board before the full UK ME/CFS Biobank Application is submitted. Please feel free to make contact with the biobank through the Contact Us page to discuss the application process and/or your proposal.
The UK ME/CFS Biobank services are provided on a cost recovery basis and this information is only available on request.